| Jeffrey M. Leiden Born: c. 1953
Gender: Male
Race or Ethnicity: White
Occupation: Doctor Nationality: United States
Executive summary: Clarus Ventures University: AB, University of Chicago (1975)
University: PhD, University of Chicago (1979)
Medical School: MD, University of Chicago (1981)
Professor: Medicine, University of Michigan
Professor: Medicine and Pathology, University of Chicago (1992-99)
Professor: Biological Sciences, Harvard School of Public Health (1999-2000)
Administrator: Trustee, University of Pennsylvania School of Medicine
Clarus Ventures Managing Director (2007-)
Clarus Ventures Partner (2006-07)
Abbott Laboratories President and COO, Pharmaceuticals Products (2001-06)
Abbott Laboratories EVP Pharmaceuticals, Chief Scientific Officer (2000-01)
Member of the Board of Abbott Laboratories (2001-06)
Member of the Board of Biolex Therapeutics
Member of the Board of Lycera Corporation
Member of the Board of Shire plc (2007-)
Member of the Board of TAP Pharmaceutical Products, Inc. (2001-06)
Member of the Board of TyRx Pharma (as Chairman)
Member of the Board of Variation Biotechnologies Inc. (as Chairman)
Member of the Board of Vertex Pharmaceuticals (2009-)
American Academy of Arts and Sciences 2001
American Society for Clinical Investigation
Association of American Physicians
Institute of Medicine
Requires Flash 7+ and Javascript.
Do you know something we don't?
Submit a correction or make a comment about this profile
Copyright ©2019 Soylent Communications
| 
